Literature DB >> 19932850

Fluid residuals and drug exposure in nasal irrigation.

Richard J Harvey1, Nick Debnath, Aviva Srubiski, Ben Bleier, Rodney J Schlosser.   

Abstract

OBJECTIVE: Topical treatment options in chronic rhinosinusitis (CRS) are growing with our increased understanding of the inflammatory process. Additives to irrigation devices have become popular. Additives such as menthol provide little more than sensory feedback. However, glucocorticosteroids and antibiotics represent powerful pharmaceutical agents for which we have little knowledge regarding patient exposure and absorption. There is little data on fluid retained after nasal irrigation. The purpose of this study was to determine the residual volume and percentage of total nasal irrigation that is retained from a neti pot (NasaFlo) or squeeze bottle (Sinus Rinse). STUDY
DESIGN: Cross-sectional study.
SETTING: Tertiary rhinologic clinic.
METHODS: Patients with CRS were already using saline irrigation in their treatment. Participants were divided into pre and post sinus surgery (ESS). Control irrigations on 17 healthy patients with no sinonasal complaints were collected. Nasal irrigation was performed with accurate collection of the excess to determine retained amount.
RESULTS: Overall retention of fluid was 2.5 +/- 1.6 percent. This represents only 5.8 +/- 3.8 mL for the 240-mL irrigations. Squeeze bottle and neti pot were similar: 2.3 +/- 1.3 percent and 3.0 +/- 2.2 percent, respectively (P = 0.23). CRS (pre-ESS) patients had the least retained volume: 1.4 +/- 1.2 percent. Post-ESS retained volume was 2.36 +/- 1.18 percent. Control patients retained 2.2 +/- 1.2 percent.
CONCLUSIONS: Quantification of the residual volume has important implications for the treatment of inflammatory disease with saline, as well as for potentially novel topical therapies. The information helps to define the fluid dynamics during nasal irrigation. The data are important to address concerns regarding drug or salt exposure from a very common intervention.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932850     DOI: 10.1016/j.otohns.2009.09.006

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  10 in total

Review 1.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

Review 2.  Advances in the surgical management of chronic sinusitis and nasal polyps.

Authors:  Vijay R Ramakrishnan; David W Kennedy
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

3.  Randomized clinical trial to evaluate mometasone lavage vs spray for patients with chronic rhinosinusitis without nasal polyps who have not undergone sinus surgery.

Authors:  Pawina Jiramongkolchai; Andrew Peterson; Dorina Kallogjeri; Jake J Lee; Sara Kukuljan; Adam Liebendorfer; John S Schneider; Cristine N Klatt-Cromwell; Andrew J Drescher; Jay F Piccirillo
Journal:  Int Forum Allergy Rhinol       Date:  2020-05-29       Impact factor: 3.858

4.  A novel irrigation device with superior nasal irrigation efficiency to the classic rinse bottle.

Authors:  Dawei Wu; Feifan Chang; Junsheng Hong; Baihan Su; Yongxiang Wei
Journal:  J Otolaryngol Head Neck Surg       Date:  2022-05-03

5.  A computational study of functional endoscopic sinus surgery and maxillary sinus drug delivery.

Authors:  M R Wofford; J S Kimbell; D O Frank-Ito; V Dhandha; K A McKinney; G M Fleischman; C S Ebert; A M Zanation; B A Senior
Journal:  Rhinology       Date:  2015-03       Impact factor: 3.681

Review 6.  Different types of intranasal steroids for chronic rhinosinusitis.

Authors:  Lee Yee Chong; Karen Head; Claire Hopkins; Carl Philpott; Martin J Burton; Anne G M Schilder
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26

Review 7.  Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis.

Authors:  Lee Yee Chong; Karen Head; Claire Hopkins; Carl Philpott; Anne G M Schilder; Martin J Burton
Journal:  Cochrane Database Syst Rev       Date:  2016-04-26

8.  The Effectiveness of Budesonide Nasal Irrigation After Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Asthma.

Authors:  Tae Wook Kang; Jae Ho Chung; Seok Hyun Cho; Seung Hwan Lee; Kyung Rae Kim; Jin Hyeok Jeong
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-07-21       Impact factor: 3.372

9.  Efficacy of syringe-irrigation topical therapy and the influence of the middle turbinate in sinus penetration of solutions.

Authors:  Guilherme Henrique Wawginiak; Leonardo Balsalobre; Eduardo Macoto Kosugi; João Paulo Mangussi-Gomes; Raul Ernesto Samaniego; Aldo Cassol Stamm
Journal:  Braz J Otorhinolaryngol       Date:  2016-07-31

10.  Topical therapy with high-volume budesonide nasal irrigations in difficult-to-treat chronic rhinosinusitis.

Authors:  Eduardo Macoto Kosugi; Guilherme Figner Moussalem; Juliana Caminha Simões; Rafael de Paula e Silva Felici de Souza; Vitor Guo Chen; Paulo Saraceni Neto; José Arruda Mendes Neto
Journal:  Braz J Otorhinolaryngol       Date:  2015-09-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.